Thousands of people across the United Kingdom are experiencing a mysterious and debilitating skin disorder that has stumped doctors. Sufferers report their skin becoming severely inflamed, cracked and peeling, commonly affecting large areas of their body, yet many doctors struggle to diagnose or treat the condition. The condition, referred to as topical steroid withdrawal (TSW) or red skin syndrome, has generated significant attention on social media, with footage showing patients’ experiences accumulating over one billion views on TikTok alone. Although it affects a growing number of people, TSW remains so inadequately understood that some GPs and skin specialists doubt whether it exists at all. Now, in a first-of-its-kind move, researchers in the UK are undertaking a major study to investigate what is responsible for these unexplained symptoms and why some people develop the condition while others remain unaffected.
The Mysterious Ailment Spreading Across the UK
Bethany Gamble’s case exemplifies the devastating impact of topical steroid withdrawal on patients’ wellbeing. The 21-year-old from Birmingham had managed her eczema successfully with steroid creams since childhood, but at eighteen, her condition took a dramatic turn for the worse. Her skin became intensely inflamed and red, breaking and leaking whilst the itching became what she describes as “bone deep”. Within two years, the pain had become so severe that she was confined to her bed, dependent on continuous support from her mother. Most concerning, Bethany experienced repeated dismissal by doctors who attributed her symptoms to standard eczema and continued prescribing the very treatments she believed were causing her suffering.
The medical establishment remains divided on how to address TSW, with fundamental disagreement about its core nature. Some experts consider it a serious allergic reaction to the steroid-based creams that form the first-line treatment for eczema across the NHS. Others maintain it amounts to a acute flare-up of current skin conditions rather than a unique syndrome, whilst a minority are sceptical of its existence altogether. This professional uncertainty has put patients like Bethany caught in a diagnostic uncertainty, having difficulty accessing appropriate treatment. The failure to reach consensus has prompted Professor Sara Brown at the Edinburgh University to set up the inaugural major UK research project studying TSW, supported by the National Eczema Society.
- Symptoms include significant swelling, skin fissuring and persistent pruritus across the body
- Patients describe “elephant skin” hardening and extreme shedding of keratinised cells
- Healthcare practitioners frequently overlook TSW as typical dermatitis or decline to recognise it
- The condition may become so debilitating that sufferers find themselves unable to carry out everyday tasks
Living with Topical Steroid Withdrawal
From Manageable Eczema to Severe Symptoms
For many sufferers, topical steroid withdrawal constitutes a severe decline from a previously stable skin condition. What starts with intermittent itching in areas of skin fold can rapidly escalate into a widespread inflammatory reaction that leaves patients unable to function. The change typically happens suddenly, unexpectedly, transforming a manageable chronic condition into an severe medical emergency. Patients report their skin becoming intensely hot, red and inflamed, with severe cracking and oozing that demands ongoing care. The bodily burden is worsened by exhaustion, as the relentless itching disrupts sleep and recovery, establishing a vicious cycle of deterioration.
The speed at which TSW unfolds takes many sufferers off guard. Those who have lived with eczema for years, sometimes decades, are unprepared for the intensity of symptoms that appear when their condition sharply declines. Everyday tasks become monumental challenges: showering becomes agonising, dressing requires assistance, and preserving hygiene demands substantial energy. Some patients recount feeling as though their skin is being ravaged from within, with inflammation moving through their body in patterns that bear little resemblance to their previous eczema flare-ups. This marked shift often drives sufferers to obtain emergency care, only to encounter scepticism from healthcare professionals.
The Quest for Recognition
Perhaps the most distressing aspect of topical steroid withdrawal is the medical gaslighting that commonly occurs with it. Patients presenting with serious, unexplained health issues are routinely told they simply have eczema worsening, despite their insistence that this is fundamentally different from anything they’ve experienced before. Doctors often respond by prescribing stronger steroids or increased doses, possibly exacerbating the very condition patients believe the creams caused. This cycle of dismissal leaves sufferers experiencing abandonment by the medical establishment, forced to navigate their illness alone whilst being informed that their personal experience lacks validity. Many patients report feeling gaslit repeatedly, their worries disregarded as anxiety or psychological rather than genuine physiological symptoms.
The absence of professional agreement has established a significant divide between what patients report and clinical acknowledgement. Without clear diagnostic criteria or defined treatment approaches, general practitioners and skin specialists find it difficult to diagnose TSW or offer appropriate support. Some practitioners remain entirely unconvinced the condition exists, viewing all acute cases as standard eczema or other known dermatological conditions. This professional uncertainty results in diagnostic delays, inappropriate treatment and significant emotional suffering for people experiencing physical symptoms. The increased prominence of TSW on online platforms has drawn attention to this diagnostic gap, encouraging investigation to investigate what thousands of people claim to be experiencing, even as the medical establishment continues to disagree on how to respond.
- Signs may develop abruptly in individuals with previously stable eczema managed by topical steroids
- Patients often face disbelief from healthcare professionals who ascribe worsening to typical eczema exacerbations
- Healthcare providers remain divided on whether TSW is a genuine condition or severe eczema exacerbation
- Lack of diagnostic criteria means many sufferers find it difficult to obtain suitable care and assistance
- Social media has magnified patient voices, with TSW hashtags accumulating over a billion views globally
Racial Disparities in Diagnosis and Care
The diagnostic challenges surrounding TSW become increasingly evident amongst people with darker skin tones, where symptoms can be substantially more challenging to detect visually. Erythema and inflammatory responses, the characteristic indicators of TSW in lighter-skinned individuals, present distinctly across different ethnic groups, yet many assessment protocols remain focused on how the condition appears in white patients. This disparity means that Black, Asian and other people of colour experiencing TSW frequently encounter even greater delays in identification and acceptance. Medical staff trained mainly through presentations in lighter skin may miss or misread the defining features, leading to further misdiagnosis and unsuitable therapeutic suggestions that can worsen symptoms.
Research into TSW has historically overlooked the lived experiences with deeper skin tones, sustaining a pattern where their symptoms remain under-documented and under-studied. The social media conversations shaping TSW discourse have been predominantly influenced by individuals with lighter complexions, risking distortion of medical understanding and community understanding. As Professor Sara Brown’s pioneering British research advances, guaranteeing inclusive participation amongst participants will be essential to creating genuinely comprehensive diagnostic frameworks and therapeutic strategies. Without deliberate efforts to centre the experiences of diverse populations, treatment inequalities in TSW identification and care risk widening further, abandoning at-risk communities without adequate support or answers.
| Skin Tone | TSW Appearance |
|---|---|
| Light/Fair | Bright red inflammation, visible flushing and erythema across affected areas |
| Medium/Olive | Darker red or brownish discolouration with less pronounced visible redness |
| Dark/Deep | Purple-toned or ashen discolouration, with inflammation appearing as hyperpigmentation or hypopigmentation |
| Very Dark | Subtle changes in skin texture and tone, with inflammation manifesting as dark patches or loss of pigmentation |
Treatment and Research Options Developing
First Major UK Investigation Currently Happening
Professor Sara Brown’s pioneering research at the Edinburgh University marks a significant milestone for TSW sufferers seeking validation and understanding. Funded by the National Eczema Society, the study has brought together hundreds of participants across the UK to investigate the underlying mechanisms underlying topical steroid withdrawal. By analysing symptoms, saliva samples and skin biopsies, researchers aim to identify why particular individuals develop TSW whilst others using identical steroid regimens do not. This scientific scrutiny marks a notable change from dismissal to serious investigation.
The research team partnering with Dr Alice Burleigh from patient advocacy group Scratch That, brings both clinical knowledge and firsthand experience to the research. Their partnership approach acknowledges that patients themselves hold essential understanding into their health situations. Professor Brown has observed trends in TSW that cannot be explained by traditional understanding of eczema, including characteristic “elephant skin” thickening, extreme shedding and sharply demarcated inflammatory patches. The research findings could significantly transform how doctors manage diagnosis and treatment of this debilitating condition.
Available Treatments and Their Limitations
Presently, management options for TSW are quite limited and commonly disappointing. Many medical practitioners keep prescribing topical steroids despite evidence implying they might intensify symptoms in vulnerable patients. Some patients report temporary relief from moisturisers, antihistamines and systemic drugs, though responses vary considerably. Dermatologists remain divided on best treatment approaches, with some supporting total steroid discontinuation whilst others suggest slow reduction. This shortage of unified guidance sees patients managing their care journeys largely alone, depending significantly on peer support networks and online communities for advice.
Psychological assistance with specialist dermatological care offer potential benefits, yet access is inconsistent across the NHS. Some patients have investigated complementary methods including dietary modifications, managing environmental factors and holistic therapies, though scientific evidence validating such approaches remains sparse. The absence of established clinical protocols means treatment decisions frequently rely upon individual dermatologist experience and patient preference rather than evidence-based guidelines. Until robust research produces definitive answers, TSW sufferers frequently describe experiencing abandonment by conventional medicine.
- Emollients and moisturisers to maintain skin barrier function and reduce water loss
- Antihistamine medications to control pruritus and associated sleep disruption during flare-ups
- Systemic corticosteroids or immunosuppressants for serious presentations with specialist oversight
- Mental health support to manage emotional distress and worry stemming from chronic skin conditions
Testimonies of Aspiration and Perseverance
Despite the ambiguity surrounding TSW and the often dismissive perspectives from medical practitioners, patients are drawing strength in shared community and shared experience. Digital support communities have emerged as lifelines for those struggling with the condition, offering validation and practical advice when traditional medicine has failed them. Many sufferers describe the point at which they found the TSW hashtag as pivotal—finally connecting with others with the same symptoms and realising they were not isolated in their suffering. This collective voice has been powerful enough to spark the first serious research efforts, demonstrating that patient advocacy can advance medical understanding even when institutional structures remain sceptical.
Bethany Gamble and people in similar situations are resolved to raise awareness and advocate for appropriate acknowledgement of TSW within the healthcare sector. Their willingness to share deeply personal accounts of their challenges on social media has normalised conversations around a condition that many doctors still refuse to acknowledge. These individuals are not remaining passive for responses; they are actively participating in research studies, documenting their symptoms meticulously, and demanding that their experiences be treated with respect. Their resilience in the confronting persistent distress and medical gaslighting suggests possibility that responses might prove to be within reach, and that upcoming sufferers will obtain the recognition and support they urgently require.
- Patient-led research initiatives are addressing shortcomings overlooked by traditional medical institutions and accelerating understanding of TSW
- Digital support networks provide psychological assistance, actionable management techniques, and peer validation for affected individuals worldwide
- Campaign work are incrementally changing medical perception, prompting dermatologists to examine rather than overlook individual accounts
